Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Invested Capital: 2023-2025

Historic Invested Capital for CG Oncology (CGON) over the last 2 years, with Sep 2025 value amounting to $687.6 million.

  • CG Oncology's Invested Capital rose 28.11% to $687.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $687.6 million, marking a year-over-year increase of 28.11%. This contributed to the annual value of $733.4 million for FY2024, which is 695.76% up from last year.
  • Latest data reveals that CG Oncology reported Invested Capital of $687.6 million as of Q3 2025, which was up 2.58% from $670.4 million recorded in Q2 2025.
  • CG Oncology's 5-year Invested Capital high stood at $733.4 million for Q4 2024, and its period low was -$123.1 million during Q4 2023.
  • For the 3-year period, CG Oncology's Invested Capital averaged around $541.4 million, with its median value being $619.6 million (2024).
  • Data for CG Oncology's Invested Capital shows a peak YoY spiked of 695.76% (in 2024) over the last 5 years.
  • Over the past 3 years, CG Oncology's Invested Capital (Quarterly) stood at -$123.1 million in 2023, then skyrocketed by 695.76% to $733.4 million in 2024, then grew by 28.11% to $687.6 million in 2025.
  • Its Invested Capital was $687.6 million in Q3 2025, compared to $670.4 million in Q2 2025 and $704.8 million in Q1 2025.